Summary
The quality of molecular electrostatic maps generated by non-quantum mechanical methods has been improved using extended electron distributions. Further simplification has been achieved by distilling these maps down to their energy extrema. A new means of defining surface interaction has been added and the resulting composite map has been plotted for a limited number of low-lying conformers of a series of agonists and antagonists of the H2 and H3 receptors and 5-HT1A and 5-HT1D receptors. The results from the cross-comparison of these maps indicate their ability to distinguish the specific receptor. Interesting consequences of the method are that structural overlay is irrelevant, that several conformations may contribute to the overall binding pattern and that lesser pharmacological activities may be deduced from the results.
Similar content being viewed by others
References
Vinter, J.G., J. Comput.-Aided Mol. Design, 8 (1994) 653.
CramerIII, R.D., Patterson, D.E. and Bunce, J.D., J. Am. Chem. Soc., 110 (1988) 5959.
Chau, P.-L. and Dean, P.M., J. Comput.-Aided Mol. Design, 8 (1994) 513.
Davis, A., Warrington, B.H. and Vinter, J.G., J. Comput.-Aided Mol. Design, 1 (1987) 97.
Vinter, J.G. and Saunders, M.R., In Sutherland, I.O. (Ed.) Host-Guest Molecular Interactions: from Chemistry to Biology, Ciba Foundation Symposium Series No. 158, Wiley, London, 1991, pp. 249–261.
Apaya, R.P., Lucchese, B., Price, S.L. and Vinter, J.G., J. Comput.-Aided Mol. Design, 9 (1995) 33.
Finn, W., In Vinter, J.G. and Gardner, M. (Eds.) Molecular Modelling and Drug Design, Topics in Molecular and Structural Biology Series, Macmillan Press, London, 1994, pp. 266–299.
Vinter, J.G. and Trollope, K.I., manuscript in preparation.
Morley, S.D., Abraham, R.J., Haworth, I.S., Jackson, D.E., Saunders, M.R. and Vinter, J.G., J. Comput.-Aided Mol. Design, 5 (1991) 475.
Atkins, P.W., Physical Chemistry, 4th ed., Oxford University Press, Oxford, 1990, pp. 959–960.
Lockhart, D.J. and Kim, P.S., Science, 257 (1992) 947.
Abraham, R.J., Edgar, M., Griffiths, L. and Powell, R.L., J. Chem. Soc., Chem. Commun., (1993) 1544.
MIN01 in COSMIC; Vinter, J.G., Davis, A. and Saunders, M.R., J. Comput.-Aided Mol. Design, 1 (1987) 31. The full details of MIN01 were never published due to an oversight. Its coincidental similarity to the recently published CEDD method of Treasurywala and co-workers [Jaefer, E.P., Peterson, M.L. and Treasurywala, A.M., J. Comput.-Aided Mol. Design, 9 (1995) 55] now makes this task unnecessary. Other conformational hunters, e.g. in MacroModel or SYBYL, have been used successfully.
In accordance with the Reaction Isotherm, less than 0.1% of the higher energy conformer will exist at body temperature when it lies 2.7 kcal/mol above the lowest energy conformer.
The primary sorting factor, to select the best 50 overlays, uses the Coulombic overlay energy only. Although this is regarded as an ‘energy’, its quantitative value has no physical significance because such interactions would not occur in nature. Fields of this kind reorganise themselves as the two species closely approach and finally dock. However, recent work (not reported here) has suggested that Coulombic overlay energies may reflect a qualitative binding strength order. Secondary factors, used to order the 50 overlays in different ways, need to (i) take account of the excess or relief of energy necessary for the receptor to incorporate a given conformation; and (ii) consider that an overlay between drug conformers and a specific common conformer may occur more than once and be included in some ‘entropic’ adjustment. Furthermore, Boltzmann statistics need to be applied across the comparisons. These issues are being addressed.
Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.H., Martin, G.R., Myecharane, E.J., Saxena, P.R. and Humphrey, P.P.A., Pharmacol. Rev., 46 (1994) 157.
Conner, H.E., O'Shaughnessy, C.T., Feniuk, W., Perren, M.J., North, P.C., Oxford, A.W., Butina, D., Owen, M. and Humphrey, P.P.A., Br. J. Pharmacol., 108(s) (1993) 99P.
Cliffe, I.A., Brightwell, C.I., Fletcher, A., Forster, E.A., Mansell, H.L., Reilly, Y., Routledge, C. and White, A.C., J. Med. Chem., 36 (1993) 1509.
Skingle, M., Scopes, D.I.C., Feniuk, W., Connor, H.E., Carter, M.C., Clitherow, J.W. and Tyers, M.B., Br. J. Pharmacol., 110(s) (1993) 9P.
Fletcher, A., Cliffe, I.A. and Dourish, C.T., Trends Pharmacol. Sci., 14 (1993) 441.
Schwartz, J.-C., Arrang, J.-M., Garbarg, M. and Pollard, H., Agents Actions, 30 (1990) 13.
Shankley, N.P., Black, J.W., Ganellin, C.R. and Mitchell, R.C., Br. J. Pharmacol., 94 (1988) 264.
Watt, G.F. and Shankley, N.P. (1994) James Black Foundation, London, personal communication.
Garbarg, M., Arrang, J.-M., Rouleau, A., Ligneau, X., Dam Trung Tuong, M., Schwartz, J.-C. and Ganellin, C.R., J. Pharmacol. Therapeut., 263 (1992) 304.
Eriks, J.C., Van derGroot, H., Sterk, G.J. and Timmerman, H., J. Med. Chem., 17 (1992) 3239.
Eriks, J.C., Van derGroot, H. and Timmerman, H., Mol. Pharmacol., 44 (1993) 886.
We have completed a fuller study, to be published in due course, accounting for tautomeric variability. This has suggested a subtle interplay of 1N- and 3N-tautomeric interchanges in histamine which seems to correlate with agonism and antagonism (see Nederkoorn, P.H.J., Vernooijs, P., Donné-Op den Kelder, G.M., Baerends, E.J. and Timmerman, H., J. Mol. Graphics, 12 (1994) 242). There is no justification in reproducing the individual conformers of histamine in Fig. 9, as they are only variations on the 1N-tautomer. However, it is worth noting that, even at the elementary level of analysis presented here, the conformers associated with a particular colour code were members of distinct conformational families, in a similar way to those found for 5-HT.
Topiol, S. and Sabio, M., J. Comput.-Aided Mol. Design, 5 (1991) 263.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vinter, J.G., Trollope, K.I. Multiconformational composite molecular potential fields in the analysis of drug action. I. Methodology and first evaluation using 5-HT and histamine action as examples. J Computer-Aided Mol Des 9, 297–307 (1995). https://doi.org/10.1007/BF00125171
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00125171